NEW YORK (GenomeWeb News) – Millipore today said that its shareholders have voted in favor of the firm's acquisition by Germany's Merck KGaA.
The Billerica, Mass.-based research products firm said that shareholders representing around 79 percent of its shares voted, with 98 percent voting in favor of the deal.
The firm agreed to the $7.2 billion deal earlier this year, with Merck offering $107 per share in cash for all outstanding shares of Millipore. The deal was announced several days after reports had surfaced that thermo Fisher Scientific had made a $6 billion bid for Millipore.
Completion of the deal still requires clearance from US antitrust authorities. The partners hope to complete the acquisition early in the third quarter of 2010.